196 related articles for article (PubMed ID: 1363378)
21. Inhibition of HIV-1 in vitro by C-5 propyne phosphorothioate antisense to rev.
Lund OS; Nielsen JO; Hansen JE
Antiviral Res; 1995 Sep; 28(1):81-91. PubMed ID: 8585762
[TBL] [Abstract][Full Text] [Related]
22. Shutting down a gene. Antisense drug wins approval.
Stix G
Sci Am; 1998 Nov; 279(5):46, 50. PubMed ID: 9841380
[No Abstract] [Full Text] [Related]
23. A new class of anti-HIV-1 oligonucleotide targeted to the polypurine tract of viral RNA.
Hiratou T; Miyano-Kurosaki N; Gushima H; Takaku H
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):715-8. PubMed ID: 11563099
[TBL] [Abstract][Full Text] [Related]
24. Sequence-specific inhibition of gene expression by a novel antisense oligodeoxynucleotide phosphorothioate directed against a nonregulatory region of the human immunodeficiency virus type 1 genome.
Anazodo MI; Wainberg MA; Friesen AD; Wright JA
J Virol; 1995 Mar; 69(3):1794-801. PubMed ID: 7853519
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and tissue distribution in rats of an oligodeoxynucleotide phosphorothioate (GEM 91) developed as a therapeutic agent for human immunodeficiency virus type-1.
Zhang R; Diasio RB; Lu Z; Liu T; Jiang Z; Galbraith WM; Agrawal S
Biochem Pharmacol; 1995 Mar; 49(7):929-39. PubMed ID: 7741765
[TBL] [Abstract][Full Text] [Related]
26. Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion.
Wyatt JR; Vickers TA; Roberson JL; Buckheit RW; Klimkait T; DeBaets E; Davis PW; Rayner B; Imbach JL; Ecker DJ
Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1356-60. PubMed ID: 7906414
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of HIV-1 replication by triple-helix-forming phosphorothioate oligonucleotides targeted to the polypurine tract.
Tsukahara S; Suzuki J; Hiratou T; Takai K; Koyanagi Y; Yamamoto N; Takaku H
Biochem Biophys Res Commun; 1997 Apr; 233(3):742-7. PubMed ID: 9168925
[TBL] [Abstract][Full Text] [Related]
28. Antisense phosphorothioate oligodeoxynucleotides alter HIV type 1 replication in cultured human macrophages and peripheral blood mononuclear cells.
Weichold FF; Lisziewicz J; Zeman RA; Nerurkar LS; Agrawal S; Reitz MS; Gallo RC
AIDS Res Hum Retroviruses; 1995 Jul; 11(7):863-7. PubMed ID: 7546914
[TBL] [Abstract][Full Text] [Related]
29. Technology evaluation: fomivirsen, Isis Pharmaceuticals Inc/CIBA vision.
Orr RM
Curr Opin Mol Ther; 2001 Jun; 3(3):288-94. PubMed ID: 11497353
[TBL] [Abstract][Full Text] [Related]
30. Antiviral activity and protection of cells against human immunodeficiency virus type-1 using an antisense oligodeoxyribonucleotide phosphorothioate complementary to the 5'-LTR region of the viral genome.
Anazodo MI; Salomon H; Friesen AD; Wainberg MA; Wright JA
Gene; 1995 Dec; 166(2):227-32. PubMed ID: 8543166
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of human immunodeficiency virus type 1 infection in SCID-hu Thy/Liv mice by the G-quartet-forming oligonucleotide, ISIS 5320.
Stoddart CA; Rabin L; Hincenbergs M; Moreno M; Linquist-Stepps V; Leeds JM; Truong LA; Wyatt JR; Ecker DJ; McCune JM
Antimicrob Agents Chemother; 1998 Aug; 42(8):2113-5. PubMed ID: 9687417
[TBL] [Abstract][Full Text] [Related]
32. Antisense oligonucleotide treatment of inflammatory bowel diseases.
Yacyshyn BR
Methods Mol Med; 2005; 106():295-305. PubMed ID: 15375323
[No Abstract] [Full Text] [Related]
33. Synergistic inhibition of HIV-1 by an antisense oligonucleotide and nucleoside analog reverse transcriptase inhibitors.
Veal GJ; Agrawal S; Byrn RA
Antiviral Res; 1998 Apr; 38(1):63-73. PubMed ID: 9614005
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of mouse hepatitis virus multiplication by phosphorothioate analogues of oligodeoxynucleotides complementary to the leader RNA.
Hayashi M; Maeda A; Watanabe T; Hanaki K; Arai S; Nozaki S
J Vet Med Sci; 1995 Dec; 57(6):1081-3. PubMed ID: 8720052
[TBL] [Abstract][Full Text] [Related]
35. Mixed-backbone oligonucleotides as second generation antisense oligonucleotides: in vitro and in vivo studies.
Agrawal S; Jiang Z; Zhao Q; Shaw D; Cai Q; Roskey A; Channavajjala L; Saxinger C; Zhang R
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2620-5. PubMed ID: 9122245
[TBL] [Abstract][Full Text] [Related]
36. Immune stimulation by an antisense oligomer complementary to the rev gene of HIV-1.
Branda RF; Moore AL; Mathews L; McCormack JJ; Zon G
Biochem Pharmacol; 1993 May; 45(10):2037-43. PubMed ID: 8512586
[TBL] [Abstract][Full Text] [Related]
37. Phosphorothioate G3T4G3 motifs inhibits the early stage of HIV-1 infection.
Suzuki J; Miyano-Kurosaki N; Takeuchi H; Tamura Y; Kawai G; Takai K; Tanaka Y; Tanaka R; Yamamoto N; Takaku H
Nucleic Acids Symp Ser; 1999; (42):227-8. PubMed ID: 10780462
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of an anti-human immunodeficiency virus antisense oligodeoxynucleotide phosphorothioate (GEM 91) in HIV-infected subjects.
Zhang R; Yan J; Shahinian HK; Amin G; Lu Z; Liu T; Saag MS; Jiang Z; Temsamani J; Martin RR
Clin Pharmacol Ther; 1995 Jul; 58(1):44-53. PubMed ID: 7628182
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of HIV-1 replication by a two-strand system (FTFOs) targeted to the polypurine tract.
Hiratou T; Tsukahara S; Miyano-Kurosaki N; Takai K; Yamamoto N; Takaku H
FEBS Lett; 1999 Jul; 456(1):186-90. PubMed ID: 10452555
[TBL] [Abstract][Full Text] [Related]
40. Specific inhibition of influenza virus RNA polymerase and nucleoprotein genes expression by liposomally endocapsulated antisense phosphorothioate oligonucleotides: penetration and localization of oligonucleotides in clone 76 cells.
Hatta T; Takai K; Nakada S; Yokota T; Takaku H
Biochem Biophys Res Commun; 1997 Mar; 232(2):545-9. PubMed ID: 9125219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]